by Orfenix | Oct 17, 2024 | Blog
Orfenix welcomes a recently published report of the Medicines Patent Pool, in partnership with Boston Consulting Group, shows how voluntary licensing brings both improved access to medicines, in particular in low and middle-income countries and economic benefits to...
by Orfenix | Oct 17, 2024 | Blog
Orfenix is proud to announce that Ivo de Nooijer has formally joined Orfenix as a shareholder and partner as of 1 July 2024. Vincent van de Wel, the founder, said, “Ivo joining this team is the next step in the development of Orfenix; Ivo brings extensive expertise in...
by Orfenix | Jul 25, 2024 | Blog
It is no secret that much money is involved in the pharmaceutical industry. Many types of medicine are expensive to develop and manufacture. The financing of healthcare is very complex. The pharmaceutical industry is exciting, but sometimes rightly, sometimes wrongly,...
by Orfenix | Jul 19, 2024 | Blog
Orfenix focuses on making innovative Life Sciences and Health solutions accessible and affordable. For example, they run projects to make specific medications available to patients affordably. They achieve this by developing strong business cases prioritizing a fair...
